Found: 15
Select item for more details and to access through your institution.
Clinical characteristics of patients treated with immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: CS-Lung-003 prospective observational registry study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 2, p. 1, doi. 10.1007/s00432-024-05618-4
- By:
- Publication type:
- Article
First and repeat rebiopsy for detecting EGFR T790M mutation in non-small-cell lung cancer: CS-Lung-003 prospective observational registry study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 8, p. 1869, doi. 10.1007/s00432-021-03893-z
- By:
- Publication type:
- Article
MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25728-8
- By:
- Publication type:
- Article
Identification of targetable kinases in idiopathic pulmonary fibrosis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Randomized study comparing mannitol with furosemide for the prevention of cisplatin‐induced renal toxicity in non‐small cell lung cancer: The OLCSG1406 trial.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2021, v. 17, n. 1, p. 101, doi. 10.1111/ajco.13423
- By:
- Publication type:
- Article
Efficacy and Safety of Re-administration of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) After EGFR-TKI-Induced Interstitial Lung Disease (CS-Lung-005).
- Published in:
- Lung, 2024, v. 202, n. 1, p. 63, doi. 10.1007/s00408-023-00669-9
- By:
- Publication type:
- Article
Statistical analysis of <sup>18</sup>F-fluorodeoxyglucose positron-emission tomography/computed tomography ground-glass nodule findings.
- Published in:
- Molecular & Clinical Oncology, 2018, v. 9, n. 3, p. 279, doi. 10.3892/mco.2018.1670
- By:
- Publication type:
- Article
Novel prospective umbrella‐type lung cancer registry study for clarifying clinical practice patterns: CS‐Lung‐003 study protocol.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 5, p. 725, doi. 10.1111/1759-7714.13789
- By:
- Publication type:
- Article
Ramucirumab‐induced ascites with endothelial growth factor receptor mutation‐positive non‐small cell lung cancer: Two case reports.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Patients' preferences and perceptions of lung cancer treatment decision making: results from Okayama lung cancer study group trial 1406.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Triple therapy with osimertinib, bevacizumab and cetuximab in EGFR-mutant lung cancer with HIF-1α/TGF-α expression.
- Published in:
- Oncology Letters, 2021, v. 22, n. 3, p. N.PAG, doi. 10.3892/ol.2021.12900
- By:
- Publication type:
- Article
Detection of epidermal growth factor receptor mutations in exhaled breath condensate using droplet digital polymerase chain reaction.
- Published in:
- Oncology Letters, 2020, v. 20, n. 6, p. N.PAG, doi. 10.3892/ol.2020.12256
- By:
- Publication type:
- Article
Cerebral venous sinus thrombosis concomitant with leptomeningeal carcinomatosis, in a patient with epidermal growth factor receptor-mutated lung cancer.
- Published in:
- Oncology Letters, 2014, v. 8, n. 6, p. 2489, doi. 10.3892/ol.2014.2603
- By:
- Publication type:
- Article
Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK‐rearranged non‐small cell lung cancer.
- Published in:
- Cancer Science, 2023, v. 114, n. 11, p. 4343, doi. 10.1111/cas.15958
- By:
- Publication type:
- Article
VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers.
- Published in:
- Cancer Science, 2021, v. 112, n. 5, p. 1853, doi. 10.1111/cas.14801
- By:
- Publication type:
- Article